Huntington`s Disease - Lake Forest College
Transcription
Huntington`s Disease - Lake Forest College
Huntington’s Disease Dillon Gilbow, Lauren Leeber, Ashley Reich Biology Department, Lake Forest College, Illinois, 60045 What is Huntington’s? • Neurodegenerative disease • Characterized by aggregates of misfolded proteins • If gene is inherited the disease is acquired • Can be detected through blood test • NO KNOWN CURE A Molecular Look into the Hunt Hunting for Relief Pathway in Huntington’s Disease Treatment for Chorea Symptoms Tetrabenazine Neuroleptics Benzodiazepines Inhibits VMAT-2 Blocks Dopamine Receptors Potentiates GABA Receptors Post Synaptic Membrane George Huntington Post Synaptic Membrane http://upload.wikimedia.org/wikipedia/commons/9/9f/Georgehuntington.jpg Onset v. Repeats Symptoms Age Treatment for Psychiatric Symptoms Presynaptic Membrane Reuptake Selective Serotonin Reuptake Inhibitors Serotonin CAG Repeats Correlation between the number of CAG repeats and age of onset Death Serotonin Huntinton’s Neuron v. Normal Neuron Post Synaptic Membrane Phases of signs and symptoms as disease progresses Huntingtin Protein Post Synaptic Membrane The Hunt for Knowledge What research is being done for Huntington’s Disease? CAG nucleotide sequence AKA: Polyglutamine tract Location: Chromosome 4 Codes for: Glutamine • Why are cells dying specifically in the striatum? • Are neural transplants a viable form of treatment? CAGCAGCAGCAGCAGCAGCAGCAGCAG mHtt Function: Not clearly known Normal Htt: <36 repeats CAG Mutant Htt: >36 repeats CAG repeats of CAG, the more severe pathology mHtt forms aggregates • What molecular pathways are there to degrade protein aggregates? • Can gene mutations help with possible therapies for HD? Mutant Huntingtin * More Coronal brain section. Severe striatal atrophy in Huntington’s patient (left) and control (right) References • Cattaneo, E., Rigamonti, D., Zuccato, C. (2002) Enigma of Huntington’s Disease. Scientific American. mHtt mHtt mHtt mHtt 92-97. • Andrich, J., Epplen, J.T., (2006) Hunting for Answers. Scientific American. 70-75. • Hayden, M.R., Kremer, B. Huntington’s Disease in The Metabolic and Molecular Bases of Inherited Disease, (eds Scriver, C.R., Beaudet, A.L., Sly, W.S. & Valle, D.)843−896 (McGraw-Hill, Inc., New York, 1995). • "Huntington's Disease Information Page." National Institute of Neurological Disorders and Stroke (NINDS). Web. 02 Apr. 2010. <http://www.ninds.nih.gov/disorders/huntington/huntington.htm>. Acknowledgments Lauren, Allie and Dillon would like to thank their peer mentors Keith Solvang, Liza Pahomov, and Abbey Pipkorn for taking so much time out of their busy schedule to offer their guidance and wisdom. We would also like to thank Alina Konnikova, as well as the other Bio346 students. A special thanks to Dr. DebBurman for his never-ending willingness to help us this semester. Medical Mysteries of HD Dillon Gilbow, Lauren Leeber, Ashley Reich Biology Department, Lake Forest College, Illinois, 60045 Hunting for Mutants Hunting for Striatal Cells GAP GAP Why is there cell death in the striatum? Why does Htt only kill striatal cells? 1 FINDINGS 1 Rhes binds to mutant huntingtin 2 Rhes decreases aggregation of mHtt 3 Rhes acts as an E3 protein in sumoylation 4 Cysteine is required for mHtt Htt Rhes 2 mHtt mHtt Rhes A phosphomimetic (SD) mutation or a phosphoresistant (SA) mutation will help relieve motor and behavioral deficits, aggregation, and neurodegeneration. Rhes UBC Rhes mHtt E1 Rhes C263 to Serine Rhes CELL SURVIVAL http://upload.wikimedia.org/wikipedia/commons/thumb/3/33/BrainCaudatePutamen.svg/172pxBrainCaudatePutamen.svg.png Reference: Srinivasa Subramaniam, et al. (2009). Rhes, a Striatal Specific Protein, Mediates Mutant-Huntingtin Cytotoxicity. Science. 324:1327-1330. 2 1 Mice with the SD mutation live and are healthy, mice with the SA mutation die. 2 Mice with any of the SA mutation usually died in vitro, all died from HD eventually, those mice with the SD mutation were healthy. Inflammatory response How can mutant huntingtin protein be degraded? 1 2 Grafts do not survive long term Death of projection neurons 4 Inflammatory response targets grafts To target a pathway to degrade mutant huntingtin and increase cell survival. Htt T cells Patient with Huntington’s Natural Killer 10 YEARS LATER 2 FINDINGS Faster Death Projection Neuron Death More severe case 3 Grafted neurons die faster than patient’s neurons 3 GOAL Natural Killer FINDINGS -/SD -/SD -/SD -/SA DEAD DEAD +/SD HEALTHY 1 Lysine K444 Lysine K444 Lysine K444 Ac Ac Lysine K444 Ac Lysine K444 HDAC 1 Lysine K444 Lysine K444 AcHAT Ac Ac HDA HDAC 2 Lysine K444 HAT Lysine K444 Ac HAT and deacetylated by HDAC. 2 Inhibition of HDAC and increase in HAT leads to . an the degradation of mHtt 3 Mutations on lysine may prevent acetylation and leads to an increase in cell death. http://blogs.abc.net.au/photos/uncategorized/2008/06/27/body.gif http://scienceblogs.com/purepedantry/upload/2007/04/hippocampus-2.gif HAT Lysine K444 The lysine of mutant 1 jjjhuntingtin is acetylated by and increased cell survival. 3 Patient still has Huntington’s Reference: Cicchetti, F., et al. (2009). Neural Transplants in Patients with Huntington’s Disease Undergo Disease-like Neuronal Degeneration. PNAS. 106: 12483-12488. -/SD Reference: Gu, X., et al. (2009) Serines 13 and 16 are Critical Determinants of Full Length Mutant Huntingtin Induced Pathogenesis in HD Mice. Neuron. 64:828-840. Rhes To replace dying cells as a viable treatment -/SA Hunting for a Target T helper Cell GOAL -/SD SA/SD GAP 4 Can dying neurons be replaced as a treatment? +/SD SA/SA Hunting for a Treatment GAP SA/SA FINDINGS E2 E3 4 CELL DEATH DEAD SA Rhes STRONG WEAK Area of striatal cell death 3 mHtt Rhes SD GOAL GOAL Identify the striatal specific protein, Rhes, role in HD HEALTHY 1 Can adding mutations on serines 13 and 16 in transgenic mice lead to a possible therapy for Huntington’s Disease? Lysine K444 Arginine R444 Arginine R444 Ac 3 Arginine R444 References: Jeong, H., et al. (2009). Acetylation Targets Mutant Huntingtin to Autophagosome Degradation. Cell. 137: 60-72. HDAC